Hienra Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Hienra Drugs Private Limited

Hienra Drugs Private Limited, a struck off private limited company, was established on 22 February 2007 in Hyderabad, Telangana, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24232TG2007PTC052919. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nagamani Motati (Director), Shanmukha Chaitanya Reddy Motati (Director). Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 2-1-745, #101, Manohar Apartments Vidyanagar, Hyderabad, Telangana, 500044.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PTC052919

  • Registration Number

    052919

  • Incorporation Date

    22 February 2007

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 11 Days
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth **** %
  • Net Worth -2.50%
  • Total Assets **** %
Company report

Hienra Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hienra Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hienra Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagamani Motati Director 22 Feb 2007 Current
Shanmukha Chaitanya Reddy Motati Director 22 Feb 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hienra Drugs.

Hienra Drugs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 2.5%.

Hienra Drugs revenue growth over time
Hienra Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 -2.50%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hienra Drugs?

In 2017, Hienra Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hienra Drugs?

Unlock and access historical data on people associated with Hienra Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hienra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hienra Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hienra Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Hienra Drugs Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Hienra Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Nagamani Motati was appointed as a Director was appointed as a Director on 22 Feb 2007 & has been associated with this company since 19 years 11 days . was documented.

  • Director Appointment

    Progress on Shanmukha Chaitanya Reddy Motati was appointed as a Director was appointed as a Director on 22 Feb 2007 & has been associated with this company since 19 years 11 days . was documented.

  • Company Incorporation

    Progress on Hienra Drugs Private Limited was registered on 22 Feb 2007 with Roc Hyderabad & aged 19 years 11 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hienra Drugs Private Limited?

The CIN of Hienra Drugs Private Limited is U24232TG2007PTC052919.

Where is Hienra Drugs Private Limited headquartered?

Hienra Drugs Private Limited is headquartered at 2-1-745, #101, Manohar Apartments Vidyanagar, Hyderabad, Telangana, 500044.

When was Hienra Drugs Private Limited incorporated?

Hienra Drugs Private Limited was incorporated on 22 February 2007.

Who are the current directors of Hienra Drugs Private Limited?

The current directors of Hienra Drugs Private Limited are

What is the primary industry of Hienra Drugs Private Limited?

The primary industry of Hienra Drugs Private Limited is Chemicals.

Is Hienra Drugs Private Limited a listed company?

Hienra Drugs Private Limited is unlisted.

What is the capital structure of Hienra Drugs Private Limited?

The authorized capital of Hienra Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Hienra Drugs Private Limited?

The compliance status of Hienra Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available